Charles S. Ryan - Sep 1, 2023 Form 3 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
President
Signature
/s/ Brendan Hannah, Attorney-in-Fact for Charles S. Ryan, Ph.D.
Stock symbol
QNCX
Transactions as of
Sep 1, 2023
Transactions value $
$0
Form type
3
Date filed
9/6/2023, 05:40 PM
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding QNCX Common Stock 74.1K Sep 1, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.